Rachel Diamant co-founded Emendo Biotherapeutics in 2016 with a group of friends. Emendo is a next generation gene editing company developing genetic medicines for severe genetic diseases. Rachel completed biotech engineering studies from the Technion (Israel) in 2000 and MSc in Neuroscience from the Weizmann Institute of Science in 2004. She is a serial entrepreneur in biotech and has been working in the field of IP strategy for over a decade. 

We talked about the role IP has in building a company and how it can be used to develop interesting products. We talked about the culture at Emendo and how career development based on skills can be extended throughout the years.  

Music:

Music credits: Funkorama Kevin MacLeod (incompetech.com)

Licensed under Creative Commons: By Attribution 3.0 License http://creativecommons.org/licenses/by/3.0/